普瑞巴林市場：按劑型、效力、用途、最終用戶、通路 - 全球預測 2023-2030

普瑞巴林的全球市場預計將大幅成長，預計2023年將達到11.2638億美元，年複合成長率為7.67%，預計2030年將達到18.989億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球普瑞巴林市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.普瑞巴林全球市場規模及預測為何？

2.在預測期內，COVID-19對全球普瑞巴林市場的阻礙因素與影響為何？

3. 在預測期內，全球普瑞巴林市場需要投資哪些產品/細分市場/應用/領域？

4.普瑞巴林在全球市場的競爭策略為何？

5. 普瑞巴林全球市場的技術趨勢和法律規範是什麼？

6.全球普瑞巴林市場主要廠商的市佔率為何？

7. 哪些型態和策略措施被認為適合普瑞巴林進入全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 癲癇和焦慮症病例呈上升趨勢
    • 政府採取有利措施提高對不安全問題的認知
    • 患有神經性疼痛的老年人口不斷增加
  • 抑制因素
    • 替代品的存在與缺乏意識
  • 機會
    • 學名藥批准增加
    • 普瑞巴林的進展與產品改進
  • 任務
    • 不良健康影響和產品召回
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 普瑞巴林市場按劑型

• 緩釋
• 口服膠囊
• 口服液
• 口服錠劑

第7章 依藥物類別分類的普瑞巴林市場

• 抗驚厥藥
• 纖維肌痛治療藥物

第8章 普瑞巴林市場：依用途

• 焦慮症
• 癲癇
• 神經性疼痛

第9章 普瑞巴林市場：依最終用戶分類

• 居家護理
• 醫院
• 調查機構
• 專科診所

第10章 普瑞巴林市場：依通路分類

• 醫院藥房
• 網路藥房
• 零售藥房

第11章美洲普瑞巴林市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第12章亞太普瑞巴林市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第13章歐洲、中東和非洲普瑞巴林市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第14章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第15章上市公司名單

第16章附錄

• 討論指南
• 關於許可證和定價

The Global Pregabalin Market is forecasted to grow significantly, with a projected USD 1,126.38 million in 2023 at a CAGR of 7.67% and expected to reach a staggering USD 1,898.90 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pregabalin Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pregabalin Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Dosage Forms, market is studied across Extended Release, Oral Capsule, Oral Solution, and Oral Tablet. The Oral Solution is projected to witness significant market share during forecast period.

Based on Drug Class, market is studied across Anticonvulsants and Fibromyalgia Agents. The Anticonvulsants is projected to witness significant market share during forecast period.

Based on Application, market is studied across Anxiety Disorder, Epilepsy, and Neuropathic Pain. The Epilepsy is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Homecare, Hospitals, Research institute, and Specialty Clinics. The Hospitals is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Retail Pharmacy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pregabalin Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pregabalin Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pregabalin Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pregabalin Market?

4. What is the competitive strategic window for opportunities in the Global Pregabalin Market?

5. What are the technology trends and regulatory frameworks in the Global Pregabalin Market?

6. What is the market share of the leading vendors in the Global Pregabalin Market?

7. What modes and strategic moves are considered suitable for entering the Global Pregabalin Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Pregabalin Market, by Dosage Forms, 2022 vs 2030
• 4.3. Pregabalin Market, by Drug Class, 2022 vs 2030
• 4.4. Pregabalin Market, by Application, 2022 vs 2030
• 4.5. Pregabalin Market, by End-Users, 2022 vs 2030
• 4.6. Pregabalin Market, by Distribution Channel, 2022 vs 2030
• 4.7. Pregabalin Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of epilepsy and anxiety disorders
    • 5.1.1.2. Favorable government initiatives for raising awareness for anxiety issues
    • 5.1.1.3. Rising geriartic population with neuropathic pain
  • 5.1.2. Restraints
    • 5.1.2.1. Presence of substitutes and lack of awareness
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising approvals of generic versions of the medicine
    • 5.1.3.2. Advancements and product enhancements for pregabalin
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects on health and product recalls
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Pregabalin Market, by Dosage Forms

• 6.1. Introduction
• 6.2. Extended Release
• 6.3. Oral Capsule
• 6.4. Oral Solution
• 6.5. Oral Tablet

7. Pregabalin Market, by Drug Class

• 7.1. Introduction
• 7.2. Anticonvulsants
• 7.3. Fibromyalgia Agents

8. Pregabalin Market, by Application

• 8.1. Introduction
• 8.2. Anxiety Disorder
• 8.3. Epilepsy
• 8.4. Neuropathic Pain

9. Pregabalin Market, by End-Users

• 9.1. Introduction
• 9.2. Homecare
• 9.3. Hospitals
• 9.4. Research institute
• 9.5. Specialty Clinics

10. Pregabalin Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Hospital Pharmacy
• 10.3. Online Pharmacy
• 10.4. Retail Pharmacy

11. Americas Pregabalin Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Pregabalin Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Pregabalin Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. FPNV Positioning Matrix
• 14.2. Market Share Analysis, By Key Player
• 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

• 16.1. Discussion Guide
• 16.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. PREGABALIN MARKET RESEARCH PROCESS
• FIGURE 2. PREGABALIN MARKET SIZE, 2022 VS 2030
• FIGURE 3. PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2022 VS 2030 (%)
• FIGURE 5. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
• FIGURE 6. PREGABALIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. PREGABALIN MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
• FIGURE 8. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 9. PREGABALIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 10. PREGABALIN MARKET DYNAMICS
• FIGURE 11. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. PREGABALIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. PREGABALIN MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 20. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 21. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PREGABALIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 5. PREGABALIN MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PREGABALIN MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PREGABALIN MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PREGABALIN MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 10. PREGABALIN MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PREGABALIN MARKET SIZE, BY FIBROMYALGIA AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. PREGABALIN MARKET SIZE, BY ANXIETY DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PREGABALIN MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 17. PREGABALIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. PREGABALIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. PREGABALIN MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. PREGABALIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. PREGABALIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. CANADA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. CANADA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. CHINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. INDIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. ITALY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ITALY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 163. ITALY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. POLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. POLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 183. POLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. QATAR PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. QATAR PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 188. QATAR PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 234. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 235. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 236. PREGABALIN MARKET LICENSE & PRICING